CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue	$ 149,432	$ 57,675
Costs and expenses
Cost of revenue	500,524	245,970
Research and development	229,803	186,076
Selling, general and administrative	168,770	223,159
Restructuring charges	22,496	0
Total cost and expenses	921,593	655,205
Loss from operations	(772,161)	(597,530)
Other income (expense), net
Interest income	40,005	0
Interest expense	(7,108)	(7,719)
Other income, net	667	956
Total other income (expense), net	(7,238)	516,567
Loss before provision for income taxes	(779,399)	(80,963)
Provision for income taxes	129	323
Net loss	(779,528)	(81,286)
Net loss attributable to common stockholders, basic	(779,528)	(81,286)
Change in fair value of dilutive warrants	0	(523,330)
Net loss attributable to common stockholders, diluted	$ (779,528)	$ (604,616)
Weighted average shares outstanding attributable to common stockholders
Basic (in shares)	1,831,725,009	1,654,322,379
Diluted (in shares)	1,831,725,009	1,681,545,859
Net loss per share attributable to common stockholders
Basic (in dollars per share)	$ (0.43)	$ (0.05)
Diluted (in dollars per share)	$ (0.43)	$ (0.36)
Other comprehensive income
Net unrealized gains on investments, net of tax	$ 4,035	$ 0
Comprehensive loss attributable to common stockholders	(775,493)	(81,286)
Change in fair value of common stock warrant liability
Other income (expense), net
Change in fair value of common stock warrant liability	$ (40,802)	$ 523,330